TY - JOUR
T1 - The diagnosis and management of rhinitis
T2 - An updated practice parameter
AU - Wallace, Dana V.
AU - Dykewicz, Mark S.
AU - Bernstein, David I.
AU - Blessing-Moore, Joann
AU - Cox, Linda
AU - Khan, David A.
AU - Lang, David M.
AU - Nicklas, Richard A.
AU - Oppenheimer, John
AU - Portnoy, Jay M.
AU - Randolph, Christopher C.
AU - Schuller, Diane
AU - Spector, Sheldon L.
AU - Tilles, Stephen A.
PY - 2008/8
Y1 - 2008/8
N2 - These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and Management of Rhinitis: An Updated Practice Parameter." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.
AB - These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and Management of Rhinitis: An Updated Practice Parameter." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.
UR - http://www.scopus.com/inward/record.url?scp=47749085883&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47749085883&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2008.06.003
DO - 10.1016/j.jaci.2008.06.003
M3 - Article
C2 - 18662584
AN - SCOPUS:47749085883
SN - 0091-6749
VL - 122
SP - S1-S84
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2 SUPPL.
ER -